Loading
No description yet: the sentence for this tag has not been written. 3 records carry it: 3 drugs.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Agilent (Dako) ER and PR immunohistochemistry: ER/PR pharmDx, ER clone EP1, PR clones PgR 636 and PgR 1294 Dako ER/PR Dako's antibodies and kit for staining the oestrogen and progesterone receptors in breast cancer tissue, cleared by the FDA between 2002 and 2017; Dako is now part of Agilent. | Approved | Breast cancer, HR-positive / HER2-negative breast cancer | test | ||
Leica Biosystems ER clone 6F11 and PR clone 16 antibodies (Novocastra, BOND) Novocastra ER 6F11 / PR 16 Leica's antibodies for staining the oestrogen receptor (clone 6F11) and progesterone receptor (clone 16) in breast cancer tissue, including ready-to-use versions for its BOND stainers. | Approved | Breast cancer, HR-positive / HER2-negative breast cancer | test | ||
VENTANA CONFIRM anti-ER (SP1) and anti-PR (1E2) antibodies CONFIRM Ventana's ready-to-use rabbit antibodies for staining the oestrogen and progesterone receptors in breast cancer tissue, cleared by the FDA in 2011 and 2012. | Approved | Breast cancer, HR-positive / HER2-negative breast cancer | test |